Literature DB >> 9252200

Heterogeneity of DNA content in multiple synchronous hepatocellular carcinomas.

A M Hui1, S Kawasaki, H Imamura, S Miyagawa, K Ishii, T Katsuyama, M Makuuchi.   

Abstract

Heterogeneity of DNA content in multiple hepatocellular carcinomas (HCCs) was investigated by flow cytometry in 62 tumours from 26 patients who had undergone surgical treatment for multiple synchronous HCCs. Heterogeneity of DNA content was defined (a) when tumours had a different DNA ploidy pattern or (b) when the difference in the DNA index of the aneuploid clone was more than 0.1. A tumour with DNA aneuploidy was observed in 17 (66%) of the 26 patients. Heterogeneity of the DNA content was demonstrated in 12 (46%) out of 26 patients: in ten cases by definition (a) and in two cases by definition (b). Histological examination revealed that, of the 12 patients with a heterogeneous tumour DNA content, seven (58%) had a heterogeneous and the remaining five (42%) had a homogeneous type and grade of differentiation among the tumours, showing the absence of a relationship between histological heterogeneity and DNA content. The present results suggest the clinical relevance of DNA content analysis for identifying the clonal origin of multiple HCCs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252200      PMCID: PMC2224061          DOI: 10.1038/bjc.1997.387

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Clonal analysis of precancerous lesion of hepatocellular carcinoma.

Authors:  T Aihara; S Noguchi; Y Sasaki; H Nakano; M Monden; S Imaoka
Journal:  Gastroenterology       Date:  1996-08       Impact factor: 22.682

2.  Clonal origin of human hepatoma determined by integration of hepatitis B virus DNA.

Authors:  M Esumi; T Aritaka; M Arii; K Suzuki; K Tanikawa; H Mizuo; T Mima; T Shikata
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

3.  Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma.

Authors:  H Tsuda; S Hirohashi; Y Shimosato; M Terada; H Hasegawa
Journal:  Gastroenterology       Date:  1988-12       Impact factor: 22.682

4.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

5.  Clonal heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis.

Authors:  L L Vindeløv; H H Hansen; I J Christensen; M Spang-Thomsen; F R Hirsch; M Hansen; N I Nissen
Journal:  Cancer Res       Date:  1980-11       Impact factor: 12.701

6.  DNA content in renal cell carcinoma with reference to tumor heterogeneity.

Authors:  B Ljungberg; R Stenling; G Roos
Journal:  Cancer       Date:  1985-08-01       Impact factor: 6.860

7.  DNA clonal heterogeneity of hepatocellular carcinoma demonstrated by Feulgen-DNA analysis.

Authors:  S H Kuo; J C Sheu; D S Chen; J L Sung; C C Lin; H C Hsu
Journal:  Liver       Date:  1987-12

8.  Convention on nomenclature for DNA cytometry. Committee on Nomenclature, Society for Analytical Cytology.

Authors:  W Hiddemann; J Schumann; M Andreef; B Barlogie; C J Herman; R C Leif; B H Mayall; R F Murphy; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1984-10

9.  Pathology of small hepatocellular carcinoma. A proposal for a new gross classification.

Authors:  T Kanai; S Hirohashi; M P Upton; M Noguchi; K Kishi; M Makuuchi; S Yamasaki; H Hasegawa; K Takayasu; N Moriyama
Journal:  Cancer       Date:  1987-08-15       Impact factor: 6.860

10.  Heterogeneity of colorectal adenocarcinomas evaluated by flow cytometry and histopathology.

Authors:  P Quirke; J E Dyson; M F Dixon; C C Bird; C A Joslin
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

View more
  3 in total

1.  Genomic heterogeneity in synchronous hepatocellular carcinomas.

Authors:  Y Sirivatanauksorn; V Sirivatanauksorn; S Bhattacharya; B R Davidson; A P Dhillon; A K Kakkar; R C Williamson; N R Lemoine
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

2.  Salvage therapy for hepatocellular carcinoma with thalidomide.

Authors:  Tsang-En Wang; Chin-Roa Kao; Shee-Chan Lin; Wen-Hsiung Chang; Cheng-Hsin Chu; Johson Lin; Ruey-Kuen Hsieh
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

3.  A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse.

Authors:  Federica Pedica; Andrea Ruzzenente; Fabio Bagante; Paola Capelli; Ivana Cataldo; Serena Pedron; Calogero Iacono; Marco Chilosi; Aldo Scarpa; Matteo Brunelli; Anna Tomezzoli; Guido Martignoni; Alfredo Guglielmi
Journal:  PLoS One       Date:  2013-07-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.